Supreme Court Hears Oral Argument in Teva Pharmaceuticals v. Sandoz

Fitzpatrick Case Update
October 15, 2014

On October 15, 2014, the Supreme Court of the United States heard oral argument in Teva Pharmaceuticals USA, Inc., et al. v. Sandoz, Inc., et al., No. 13-854. At issue in this case is whether a de novo or clear error standard applies when the Court of Appeals for the Federal Circuit reviews a district court’s factual findings in support of its claim construction (i.e., Markman) decision.

View Attachment (PDF)